Marjolein de Bruin-Weller (M de Bruin Weller, M S de Bruin-Weller, Marjolein S de Bruin-Weller, M de Bruin-Weller)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 48

Top Topics

Juvenile Idiopathic Arthritis

Atopic Dermatitis

Top Venues

The British journal of dermatology

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Coco Dekkers, Marjolein de Bruin-Weller
The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitis. The British journal of dermatology 191 (3) (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Coco Dekkers, Marjolein de Bruin-Weller
The pleiotropic role of IL-13 in AD pathogenesis. The British journal of dermatology (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Lisa P van der Rijst, Karin M de Winter-de Groot, Marjolein de Bruin-Weller, Marlies de Graaf
Reply to Sujoy Khan. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 35 (8) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Roselie E Achten, Judith L Thijs, Marlot van der Wal, Chantal van Luijk, Marlies de Graaf, Daphne S Bakker, Joke de Boer, Femke van Wijk, Marjolein de Bruin-Weller
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis. Allergy (2023)
Jonathan Ian Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, Xiaofei Hu, Sarah A Ofori, Andrew M Platt, Henrique D Teixeira, Kilian Eyerich, Jacob Pontoppidan Thyssen
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis. Dermatitis : contact, atopic, occupational, drug (2023)
Coco Dekkers, M Marlot van der Wal, Leonie van den Noort, Daphne S Bakker, Marjolein de Bruin-Weller, Femke Van Wijk
IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Jonathan Ian Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, Xiaofei Hu, Sarah A Ofori, Andrew M Platt, Henrique D Teixeira, Kilian Eyerich, Jacob Pontoppidan Thyssen
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®. Dermatitis : contact, atopic, occupational, drug 35 (3) (2023)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Roselie E Achten, Daphne S Bakker, Chantal M van Luijk, M Marlot van der Wal, Marlies de Graaf, Femke van Wijk, Nicolaas P A Zuithoff, Lisa P van der Rijst, Celeste M Boesjes, Judith L Thijs, Joke H de Boer, Marjolein de Bruin-Weller
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (6) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)
Elke L M Ter Haar, Sarah E Thomas, Juul M P A van den Reek, Marisol E Otero, Marcellus D Njoo, Paul M Ossenkoppele, E N Kop, Sharon R P Dodemont, J E M Körver, Astrid L A Kuijpers, R J Lindhout, Ron A Tupker, Johannes M Mommers, Maartje A M Berends, Marjolein I A Koetsier, Marjolein de Bruin-Weller, M B Visch, W P Arnold, Paula P van Lümig, M M Kleinpenning, Satish F K Lubeek, Elke M G J de Jong
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study. Drugs & aging 39 (9) (2022)
Lotte S Spekhorst, Lisa P van der Rijst, Marlies de Graaf, Maxime van Megen, Nicolaas P A Zuithoff, André C Knulst, Marjolein de Bruin-Weller, Thuy-My Le
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients. Allergy (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)
Angelique N Voorberg, Geertruida L E Romeijn, Marjolein de Bruin-Weller, Marie-Louise A Schuttelaar
The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry. Contact dermatitis 87 (2) (2022)
Lotte S Spekhorst, Daphne S Bakker, Julia Drylewicz, Theo Rispens, Floris Loeff, Celeste M Boesjes, Judith L Thijs, Geertruida L E Romeijn, Laura Loman, Marie-Louise Schuttelaar, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy 77 (11) (2022)
Eric L Simpson, Joseph Frank Merola, Jonathan Ian Silverberg, Kristian Reich, Richard B Warren, Delphine Staumont-Sallé, Giampiero Girolomoni, Kim A Papp, Marjolein de Bruin-Weller, Jacob P Thyssen, Rebecca Zachariae, Christiana K Olsen, Andreas Wollenberg
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials. The British journal of dermatology 187 (6) (2022)
Andreas Wollenberg, Lisa A Beck, Marjolein de Bruin-Weller, Eric L Simpson, Shinichi Imafuku, M Boguniewicz, R Zachariae, C K Olsen, Jacob Pontoppidan Thyssen
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials. The British journal of dermatology (2021)
Gil Yosipovitch, Marjolein de Bruin-Weller, April W Armstrong, Jashin J Wu, Pedro Herranz Pinto, Diamant Thaҫi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana Beatris Rossi, Jingdong Chao
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 11 (6) (2021)
Marjolein de Bruin-Weller, Andrew E Pink, Annalisa Patrizi, Gimenez-Arnau Ana Maria, Tove Agner, Pierre-Paul Roquet-Gravy, Silvia M Ferrucci, Petr Arenberger, Ake Svensson, Marie L A Schuttelaar, Audrey Nosbaum, Shyamalie Jayawardena, Elena Rizova, Marius Ardeleanu, Laurent Eckert, Zafer E Ozturk
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study. The Journal of dermatological treatment 32 (2) (2021)
Marjolein de Bruin-Weller, Joseph Frank Merola, H Chih-Ho Hong, Esther Serra Baldrich, Karel Ettler, Debra Sierka, Dimittri Delevry, Zhen Chen, Ana Beatris Rossi
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective. Dermatology and therapy 11 (6) (2021)
Christopher Ernest Maitland Griffiths, Marjolein de Bruin-Weller, Mette Deleuran, Maria-Concetta Fargnoli, Delphine Staumont-Sallé, H Chih-Ho Hong, Jose Sánchez-Carazo, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya L Cyr, Ana Beatris Rossi
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials. Dermatology and therapy 11 (4) (2021)
Daphne S Bakker, José J M Ter Linde, Mojtaba M Amini, Lieneke F M Ariëns, Chantal M van Luijk, Marjolein de Bruin-Weller, Judith L Thijs, Yvonne Vercoulen, Femke van Wijk
Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study. Allergy 76 (12) (2021)
Jart Ate Franke Oosterhaven, Lotte S Spekhorst, Junfen Zhang, Angelique N Voorberg, Geertruida L E Romeijn, Celeste M Boesjes, Marlies de Graaf, Marjolein de Bruin-Weller, Marie-Louise A Schuttelaar
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry. The Journal of dermatological treatment (2021)
Daphne S Bakker, Lieneke F M Ariëns, Barbara Giovannone, Dirk-Jan Hijnen, Eveline M Delemarre, Edward Knol, Stefan Nierkens, Marjolein de Bruin-Weller, Judith L Thijs, Julia Drylewicz
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy 75 (12) (2020)
Marjolein de Bruin-Weller
Systemic treatment in atopic dermatitis after 2018: from experienced-based treatment to evidence-based treatment? The British journal of dermatology 183 (6) (2020)
Lotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, Marijke Kamsteeg, Albert J Oosting, Ilona de Ridder, Annemiek Sloeserwij, Geertruida L E Romeijn, Marlies de Graaf, Inge Haeck, Judith L Thijs, Marie L A Schuttelaar, Marjolein de Bruin-Weller
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. Allergy 75 (9) (2020)
Marjolein de Bruin-Weller
Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis? The British journal of dermatology 181 (1) (2020)
Judith L Thijs, Renée Fiechter, Barbara Giovannone, Marjolein de Bruin-Weller, Edward F Knol, Carla A F M Bruijnzeel-Koomen, Julia Drylewicz, Stefan Nierkens, Dirk-Jan Hijnen
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity. Allergy 74 (11) (2019)
Bolanle Akinlade, Emma Guttman-Yassky, Marjolein de Bruin-Weller, E L Simpson, Andrew Blauvelt, M J Cork, E Prens, P Asbell, E Akpek, J Corren, C Bachert, I Hirano, J Weyne, A Korotzer, Z Chen, T Hultsch, X Zhu, J D Davis, L Mannent, J D Hamilton, A Teper, H Staudinger, E Rizova, G Pirozzi, N M H Graham, B Shumel, M Ardeleanu, A Wollenberg
Conjunctivitis in dupilumab clinical trials. The British journal of dermatology 181 (3) (2019)
D S Bakker, L F M Ariens, C van Luijk, J van der Schaft, J L Thijs, M L A Schuttelaar, F van Wijk, E F Knol, D M W Balak, M R van Dijk, Marjolein de Bruin-Weller
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis. The British journal of dermatology 180 (5) (2019)
Lawrence F Eichenfield, Thomas Bieber, Lisa A Beck, Eric Lawrence Simpson, Diamant Thaçi, Marjolein de Bruin-Weller, Mette Deleuran, Jonathan Ian Silverberg, Carlos Ferrandiz, Regina Fölster-Holst, Zhen Chen, Neil M H Graham, Gianluca Pirozzi, Bolanle Akinlade, George D Yancopoulos, Marius Ardeleanu
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis. American journal of clinical dermatology 20 (3) (2019)
Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, Deepak Balak, Margreet L E Romeijn, Tessa Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia Catalina Aurora van Amerongen, Evelien M Delemarre, Edward F Knol, Femke van Wijk, Stefan Nierkens, Judith L Thijs, Marie L A Schuttelaar, Marjolein de Bruin-Weller
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry. Allergy 75 (1) (2019)
Jart Ate Franke Oosterhaven, Angelique N Voorberg, Geertruida L E Romeijn, Marjolein de Bruin-Weller, Marie-Louise A Schuttelaar
Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. The Journal of dermatology 46 (8) (2019)
Judith L Thijs, Julia Drylewicz, Carla A F M Bruijnzeel-Koomen, Barbara Giovannone, Edward F Knol, Marjolein de Bruin-Weller, Stefan Nierkens, Dirk-Jan Hijnen
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A. Allergy 74 (3) (2018)
Marjolein de Bruin-Weller, D Thaçi, C H Smith, K Reich, M J Cork, A Radin, Q Zhang, B Akinlade, A Gadkari, L Eckert, T Hultsch, Z Chen, G Pirozzi, N M H Graham, B Shumel
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). The British journal of dermatology 178 (5) (2018)
Marjolein de Bruin-Weller, N M H Graham, G Pirozzi, B Shumel
Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors. The British journal of dermatology 178 (5) (2018)
Aaron Mark Drucker, K Eyerich, Marjolein de Bruin-Weller, J P Thyssen, P I Spuls, A D Irvine, G Girolomoni, S Dhar, C Flohr, Dedee Frances Murrell, A S Paller, Emma Guttman-Yassky
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. The British journal of dermatology 178 (3) (2018)
Lieneke F M Ariëns, Florine Ml Schussler-Raymakers, Cynthia Frima, Annebeth Flinterman, Eefje Hamminga, Bernd W M Arents, Carla Afm Bruijnzeel-Koomen, Marjolein de Bruin-Weller, Harmieke van Os-Medendorp
Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology. Journal of medical Internet research 19 (9) (2017)
Harmieke van Os-Medendorp, Ilse van Leent-de Wit, Marjolein de Bruin-Weller, André C Knulst
Usage and users of online self-management programs for adult patients with atopic dermatitis and food allergy: an explorative study. JMIR research protocols 4 (2) (2015)